Angela Applebee, MD
Basic profileMultiple Sclerosis Center Of Northeastern New York
Angela Applebee is a Neurology physician affiliated with Multiple Sclerosis Center Of Northeastern New York. OpenAlex indexes 28 publications with 1,728 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
63 Shaker Rd
Albany, NY 122041025
Telephone
518-429-2561Provider last certified this registry record 5 May 2021.
Clinical trials
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis
Sponsor: Acorda Therapeutics
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- EMD Serono, Inc.Program year202522 payments$37,142openpaymentsdata.cms.gov ↗
- Biogen, Inc.Program year202515 payments$19,488openpaymentsdata.cms.gov ↗
- Genentech USA, Inc.Program year202513 payments$17,573openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
84.9%Neuromuscular Blocker81.9%Onabotulinumtoxina100%Part B, office-administered≥32 patientsgamma-Aminobutyric Acid-ergic Agonist1.6%Baclofen100%Part D≥108 patients+ 3 more classes in this area
Nervous system
12.2%Gabapentinoids2.1%Gabapentin68%Pregabalin32%Part D≥92 patientsPotassium Channel Blocker1.8%Dalfampridine Er92%Ampyra8%Part D<11 patients+ 26 more classes in this area
Cancer & immunology
2.2%Pyrimidine Synthesis Inhibitor0.8%Teriflunomide73%Aubagio27%Part D<11 patientsOther immunostimulants0.5%Copaxone43%Glatiramer Acetate37%Glatopa20%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Patterns of disease-modifying therapy utilization before, during, and after pregnancy and postpartum relapses in women with multiple sclerosis
Multiple Sclerosis and Related Disorders
2024 - Altered gastrointestinal motility involving autoantibodies in the experimental autoimmune encephalomyelitis model of multiple sclerosis
Neurogastroenterology & Motility
2018
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”